KU Medical Center trial to investigate COVID-19 long range
KU Medical Center trial to investigate COVID-19 long range

KU Medical Center trial to investigate COVID-19 long range

KANSAS CITY, Mo. A new research experiment by University of Kansas Medical Center will focus on COVID-19 long distance.

Locals who suffer from the often disabling symptoms comment on their experience, as KU Lægecenter hopes to register more participants.

Mikayla Dreyer’s medical journey began before she was given the opportunity to be vaccinated against COVID-19.

“I tested positive for COVID on December 30, 2020,” Dreyer said. “My first symptoms were very classic, a dry cough that gradually got worse during the day. I took my temperature just to see and it was over 100, that was when I thought, ‘Oh no’.”

She had to isolate herself for 21 days with fever. Chest pain and shortness of breath then came.

“On my Apple Watch, I actually noticed that my heart rate kept rising, and I noticed at night that my heart rate was not slowing down,” Dreyer said.

Next, she began to experience high blood pressure and decided to go to the emergency room.

“Three and a half months after having COVID, I started getting dizzy and weak,” Dreyer said.

Dreyer remembered that she was not even able to hold the plates up, which caused her to drop and crack them.

She was admitted to the KU Medical Center’s long-distance clinic, but her problems continued.

“I actually used a wheelchair for several weeks in June,” she said. “Going from sitting to standing as many times as I did during the day made my blood pressure so unstable that I was in danger of constantly fainting.”

Dreyer reflected on the impact that COVID-19’s long cool moves have had on her.

“I had run a half marathon a few years earlier and here I am not able to walk safely,” she said.

Now those like Dreyer are eligible for a new research trial right here in Kansas City.

“The trial is called Recover. And it’s about enrolling patients who have had long-term COVID symptoms so we can better understand what exactly the syndromes we see are,” said Dr. Mario Castro from KU Medical Center.

Castro explained more about what the lawsuit hopes to achieve.

“The effect on the brain and the brain decreases cardiovascular effects on the heart, in the blood vessels, in the lungs, the patients who have shortness of breath, in patients who have the deep fatigue that leads to disability from this long COVID syndrome,” Castro said. “Our hope here at KU is to enroll nearly 200 participants here to contribute to the nationwide history of what we are trying to learn.”

Dreyer hopes to be able to contribute by signing up for the trial.

“I am not currently enrolled in the lawsuit, I plan to contact them tonight to be enrolled,” she said. “It does not have to be that way.”

We want to hear from you about what resources Kansas City families can take advantage of to help us all through the pandemic. If you have five minutes, feel free to complete this survey to help guide our coverage: KSHB COVID study.

Leave a Reply

Your email address will not be published.